424B4424B4
Sep 28, 2026Final prospectus0001193125-26-403094
All companies
Trade Adarx Pharmaceuticals Inc
AD
Adarx Pharmaceuticals Inc
ADRXPublic
PublicUnited States(NASDAQ-GS)Best valuation $1.89B1 market
Public listing
Listed· NASDAQ-GS· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
$446.25M
Sources: sec-edgar, sec-harvest, nasdaq
IPO Calendar · NASDAQ-GSIPO
ADRXPrice
$17.70
24h
-0.73%
Valuation
$1.89B
24h volume
$5.02M
Type
IPO
Trade Adarx Pharmaceuticals IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
SEC IPO filings
Final prospectusEDGAR filings resolved from ADRX / CIK 0001802369.
Sep 24, 2026Effective9999999995-26-003052
Sep 24, 2026Exchange registration0001354457-26-000906
8-A12B8-A12B
Sep 22, 2026Exchange registration0001193125-26-397868
S-1/AS-1/A
Sep 21, 2026Amended0001193125-26-396007
S-1/AS-1/A
Sep 14, 2026Amended0001193125-26-390724
S-1S-1
Sep 4, 2026Filed0001193125-26-383838
DRS/Afilename1.htm
Jul 31, 2026Confidential draft0001193125-26-328843
Jun 22, 2026Confidential draft0001193125-26-277710
Adarx Pharmaceuticals Inc IPO — frequently asked questions
- When did Adarx Pharmaceuticals Inc go public?
- Adarx Pharmaceuticals Inc has already gone public and now trades publicly on NASDAQ-GS under the ticker ADRX.
- Can I buy Adarx Pharmaceuticals Inc stock?
- Yes — Adarx Pharmaceuticals Inc is publicly traded on NASDAQ-GS as ADRX. You can follow its live price, valuation and post-IPO performance above.
- What is Adarx Pharmaceuticals Inc's valuation?
- Adarx Pharmaceuticals Inc's most recent valuation tracked here is $1.89B, derived from live market prices.